BridgeBio Pharma, Inc. (BBIO)
63.30
-2.45
(-3.73%)
USD |
NASDAQ |
Oct 13, 16:00
63.30
0.00 (0.00%)
After-Hours: 20:00
BridgeBio Pharma Free Cash Flow : -437.79M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -437.79M |
| March 31, 2026 | -452.02M |
| December 31, 2025 | -455.50M |
| September 30, 2025 | -597.61M |
| June 30, 2025 | -667.47M |
| March 31, 2025 | -509.44M |
| December 31, 2024 | -529.63M |
| September 30, 2024 | -456.32M |
| June 30, 2024 | -419.68M |
| March 31, 2024 | -605.72M |
| December 31, 2023 | -529.03M |
| September 30, 2023 | -496.70M |
| June 30, 2023 | -486.96M |
| March 31, 2023 | -407.54M |
| December 31, 2022 | -425.82M |
| September 30, 2022 | -469.32M |
| Date | Value |
|---|---|
| June 30, 2022 | -496.42M |
| March 31, 2022 | -556.07M |
| December 31, 2021 | -546.18M |
| September 30, 2021 | -508.16M |
| June 30, 2021 | -477.37M |
| March 31, 2021 | -471.56M |
| December 31, 2020 | -407.23M |
| September 30, 2020 | -386.78M |
| June 30, 2020 | -302.42M |
| March 31, 2020 | -284.62M |
| December 31, 2019 | -258.72M |
| September 30, 2019 | -227.93M |
| June 30, 2019 | -218.98M |
| March 31, 2019 | -184.20M |
| December 31, 2018 | -154.82M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Alnylam Pharmaceuticals, Inc. | 793.94M |
| Pfizer Inc. | 10.99B |
| Ionis Pharmaceuticals, Inc. | -567.50M |
| BioMarin Pharmaceutical, Inc. | 725.08M |
| Vertex Pharmaceuticals, Inc. | 3.796B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -71.10M |
| Cash from Investing (Quarterly) | 17.89M |
| Cash from Financing (Quarterly) | -148.77M |
| Free Cash Flow Per Share (Quarterly) | -0.3654 |
| Free Cash Flow to Equity (Quarterly) | -89.09M |
| Free Cash Flow to Firm (Quarterly) | -16.92M |
| Free Cash Flow Yield | -3.57% |